Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024)

Smith & Nephew (SNN) posted quarterly Cash from Investing Activities of -$360.0 million for Q4 2024, down 97.8% year-on-year from -$16.4 billion in Q1 2024, and down 97.8% on a QoQ basis from -$182.0 million in Q4 2023.

Smith & Nephew (SNN) Cash from Investing Activities (2009 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Cash from Investing Activities for 16 consecutive years, with -$360.0 million the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Investing Activities fell 97.8% year-over-year to -$360.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.2 billion (down 2.82% YoY) and the FY2025 annual result came in at -$406.0 million, up 28.65% from the prior year.
  • Cash from Investing Activities declined to -$360.0 million in Q4 2024 per SNN's latest filing, from -$182.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for SNN reached as high as -$182.0 million in Q4 2023 and fell as low as -$431.0 million in Q4 2021.
  • A 5-year average of -$313.4 million and a median of -$326.0 million in 2020 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2020 — Cash from Investing Activities soared 73.94% — and 2024, when it plunged 97.8%.
  • Year by year, Cash from Investing Activities stood at -$326.0 million in 2020, then slumped by 32.21% to -$431.0 million in 2021, then surged by 37.82% to -$268.0 million in 2022, then jumped by 32.09% to -$182.0 million in 2023, then tumbled by 97.8% to -$360.0 million in 2024.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$360.0 million, -$182.0 million, and -$268.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn -217.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -360.00 Mn
Dec 31, 2024 -360.00 Mn
Dec 31, 2023 -182.00 Mn
Dec 31, 2023 -182.00 Mn
Dec 31, 2022 -268.00 Mn
Dec 31, 2022 -268.00 Mn
Dec 31, 2021 -431.00 Mn
Dec 31, 2021 -431.00 Mn
Dec 31, 2020 -326.00 Mn
Dec 31, 2020 -326.00 Mn
Dec 31, 2019 -1.25 Bn
Dec 31, 2019 -1.25 Bn
Dec 31, 2018 -378.00 Mn
Dec 31, 2018 -378.00 Mn
Dec 31, 2017 -543.00 Mn
Dec 31, 2017 -543.00 Mn
Dec 31, 2016 -388.00 Mn
Dec 31, 2016 -388.00 Mn
Dec 31, 2015 -429.00 Mn
Dec 31, 2015 -429.00 Mn